Cancer in the Hiv-Infected Population (Data Review) Cancer in the Hiv-Infected Population (Data Review)

Cancer in the Hiv-Infected Population (Data Review‪)‬

Research Initiative/Treatment Action! 2003, Summer, 9, 1

    • 5,99 лв.
    • 5,99 лв.

Publisher Description

Cancer is a significant cause of mortality and morbidity in people infected with HIV; (1) in tact 30% to 40% will develop a malignancy during their lifetime. (2) The majority of cancers affecting HIV-positive people are those established as AIDS-defining: Kaposi's sarcoma, non-Hodgkin's lymphoma, and invasive cervical cancer. (3,4) However, other types of cancer also appear to be more common among those infected with HIV. While not classified as AIDS-defining, these malignancies are affecting the HIV/AIDS community greatly and have been referred to as "AIDS-associated malignancies" (1,5) or "opportunistic" cancers. (2) Analyses have revealed a 2- to 3-fold increase in overall risk of developing these cancers. (3,5,6) The introduction of highly active antiretroviral therapy (HAART) has resulted in decreased mortality and morbidity, (7) and the majority of people in developed countries infected with HIV are living with only mild to moderate immunosuppression because of wide access to antiretroviral therapy. (8) However, has the widespread use of these medications altered the incidence of cancer or perhaps even increased the prevalence of some types of cancer in this population? This article will present an overview of AIDS-defining malignancies and other malignancies that ate prevalent in the HIV-positive population, in addition, the effect of HAART on the incidence of these malignancies will be discussed. AIDS-DEFINING CANCERS

GENRE
Health & Well-Being
RELEASED
2003
22 June
LANGUAGE
EN
English
LENGTH
21
Pages
PUBLISHER
The Center for AIDS: Hope & Remembrance Project
SIZE
209.7
KB

More Books by Research Initiative/Treatment Action!

Late HIV Diagnosis: Predictors, Costs, Consequences, And Solutions. Late HIV Diagnosis: Predictors, Costs, Consequences, And Solutions.
2011
Body Shape Changes: Where are We? Body Shape Changes: Where are We?
2006
The Hepatitis C Drug Development Pipeline (Hcv Pipeline) The Hepatitis C Drug Development Pipeline (Hcv Pipeline)
2004
An Overview of the Biology and Viral Pathogenesis of Lymphoproliferative Disorders in Hiv-Infected Patients (Data Review) An Overview of the Biology and Viral Pathogenesis of Lymphoproliferative Disorders in Hiv-Infected Patients (Data Review)
2003
Biomedical Prevention: Has Its Time Now Come?(In Context) Biomedical Prevention: Has Its Time Now Come?(In Context)
2007
The Use of Antiretroviral Therapy in Patients Undergoing Treatment for Hiv-Related Neoplastic Disease (Clinical Considerations) The Use of Antiretroviral Therapy in Patients Undergoing Treatment for Hiv-Related Neoplastic Disease (Clinical Considerations)
2003